Suven Life Sciences Limited
NSE:SUVEN.NS
132.51 (INR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Suven Life Sciences Limited |
Symbool | SUVEN.NS |
Munteenheid | INR |
Prijs | 132.51 |
Beurswaarde | 28,896,985,740 |
Dividendpercentage | 0% |
52-weken bereik | 60.75 - 169.3 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Venkateswarlu Jasti M.Pharm. M.S. |
Website | https://www.suven.com |
An error occurred while fetching data.
Over Suven Life Sciences Limited
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)